2-CHLORO-5-FLUORO-6-METHYLNICOTINONITRILE, 95.0%, 1g

(R)-1-Boc-3-Dimethylaminopyrrolidine, 95.0%, 250mg

4-(4-TETRAHYDROPYRANYL)PHENYLBORONIC ACID PINACOL ESTER, 97.0%, 5g

2-(Benzo[d][1,3]dioxol-5-yl)ethene-1,1,2-tricarbonitrile, 95.0%, 1g

Tert-butyl(5r)-3,3-difluoro-5-hydroxy-piperidine-1-carboxylate, 98%, 100mg

1,3-Bis(trifluoromethyl)benzene, 99.00%, 25g

4,4,5,5,5-Pentafluoro-1-pentanol, 99.0%, 10g

1-Bromo-2,4,5-trimethylbenzene, 95.0%, 500g

1-Oxa-3,9-diazaspiro[5.5]undecan-2-one hydrochloride, 95.0%, 250mg

Infinity corrected plan phase S100x/1.25 objective. Working distance 0.18 mm

4,4-piperidinediyldimethanol hydrochloride, 95.0%, 5g

(S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate, 95.0%, 250mg

2-Bromo-1-[4-(dimethylamino)phenyl]ethanone, 97.0%, 250mg